Two-Punch combo trial targets tough blood cancers
NCT ID NCT03534323
Summary
This study is testing a new combination of two oral drugs, duvelisib and venetoclax, for adults with chronic lymphocytic leukemia (CLL) or Richter's syndrome that has come back or stopped responding to prior treatment. The first part of the study aims to find a safe dose when the drugs are used together. The second part will measure how well the combination works to control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Berkshire Medical Center
Pittsfield, Massachusetts, 01201, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Northern Light Eastern Maine Medical Center
Brewer, Maine, 04412, United States
-
University of Miami- Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.